Navigation Links
George Dunbar Joins Akadeum Life Sciences' Board of Directors
Date:9/7/2018

Akadeum Life Sciences today announced it has appointed George Dunbar to its Board of Directors. Dunbar has spent his career as an executive and leader of numerous biotech companies.

He most recently served as president and CEO of ISTO Biologics, a private cell therapy and biologics company acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was a Venture Partner with Arboretum Ventures, a leading life science venture capital firm.

Dunbar is joining Akadeum to work with the company on its current focused strategy of commercializing and growing its microbubble-based cell separation kits. “I’m excited to be joining Akadeum at a time when their initial products are being prepared for launch. The market has needed this type of radical simplification of next gen separation technologies,” said Dunbar.

Dunbar has served as CEO or Director for numerous public and private life science companies. In these roles, he has led several companies through their initial public offerings (IPOs) and acquisitions. He holds Electrical Engineering and MBA degrees from Auburn University.

“George has incredible expertise in the life science industry in leading in the adoption of new technologies. Having George on the team is already making a big impact on our strategy and operations,” said Akadeum’s CEO, Brandon McNaughton.

Dunbar joins existing board directors: Doug Neal, Brock Siegel, John Younger, and Brandon McNaughton. He also joins existing observers: Paul Brown, Patricia Glazier, and Charlie Moret. He will be serving in place of Bill Wood who served on the Akadeum board for over 3 years. “We are very grateful to Bill Wood for his contribution to Akadeum. His guidance, stewardship, and time on the board were critical to our success,” said McNaughton.

To learn about Akadeum and its microbubble products, visit https://www.akadeum.com/ or email info(at)akadeum.com.

About Akadeum Life Sciences, Inc.
Akadeum Life Sciences was established to create the next generation separation technology and to fundamentally change the way that isolating cells and other biological targets is approached. The company is using microbubbles to solve longstanding problems in the industry. Separation applications include research, in vitro diagnostics, and cell therapy. The company is located in Ann Arbor, MI and was founded in 2014 by Brandon McNaughton, PhD and John Younger, MD. Inquiries into Akadeum’s products or technology can be made at info(at)akadeum.com or http://www.akadeum.com/.

Read the full story at https://www.prweb.com/releases/george_dunbar_joins_akadeum_life_sciences_board_of_directors/prweb15741138.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. SCD-iBIO to Honor Purdues Dr. George Tsao for Contributions to Industrial Biotechnology
2. Lawrence Livermore Renews Pact with Georgetown University to Expand Research and Education in Science and Policy
3. CollabRx Editor-in-Chief & CMO George D. Lundberg, MD Wins 2014 ASCP Ward Burdick Award for Distinguished Service to Pathology
4. CollabRx Editor-in-Chief & CMO George D. Lundberg, MD Wins 2014 ASCP Ward Burdick Award for Distinguished Service to Pathology
5. Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15
6. Carlyle Conlan and George James Ltd Release the 2015 Life Science Trends White Paper
7. George Lauro, Distinguished Tech Entrepreneur, Joins ALine’s Board of Directors
8. RowdMap, Inc. speaks at George Washington University Health Workforce Institute Speaker Series
9. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
10. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
11. Leo Gingras Joins Nutraceutical Innovations, LLC Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, ... PolyU research team led by Dr MA has been using the zebrafish model ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering ... to 200 million stem cells. Depending on the patient's condition, treatment may be offered ... will die having some form of Alzheimers dementia, and the incidence continues to increase ...
Breaking Biology Technology:
(Date:6/23/2020)... FREDERICK, Md. (PRWEB) , ... ... ... a leading provider of gene-to-protein and monoclonal antibody development services, today announced ... of protein-based products and services to the pharmaceutical, diagnostics, and research industries. ...
(Date:6/19/2020)... ... ... The director of stem cell biotechnology company Asymmetrex , Dr. James ... industries have easier access to stem cell counting, they will soon make it a ... Day weekend in the U.S., Asymmetrex is offering free tissue stem cell counting at ...
(Date:6/11/2020)... N.H. (PRWEB) , ... June 09, 2020 , ... ... of custom industrial automation and IT solutions for the life sciences industry, is pleased ... of Business Development working out of the company’s Seabrook, New Hampshire office. In ...
Breaking Biology News(10 mins):